We conducted a series of in vitro and in vivo experiments and found that TTN-AS1 promoted the proliferation, migration, and in vivo growth of CCA cells by targeting miR-513a-5p and releasing SFN. The gene discussed is TTN; the disease is cholangiocarcinoma.